Perceptive Advisors

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Total investments 154

Average round size

The average size of a deal this fund participated in

$76M

Portfolio companies 146

Rounds per year 7.00

Lead investments 43

Follow on index

How often the fund supports its portfolio startups at next rounds

0.19

Exits 82

Key employees 3

http://www.perceptivelife.com/

https://twitter.com/PerceptiveAdvi2

United States, New York

Stages of investment

Early Stage Venture

Late Stage Venture

Private Equity

Areas of investment

Biotechnology
Health Care
Medical
Therapeutics
Pharmaceutical

Summary

The venture was found in North America in United States. The main department of described VC is located in the New York.

We also calculated 3 valuable employees in our database.

The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019. This Perceptive Advisors works on 28 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The typical startup value when the investment from Perceptive Advisors is 100-500 millions dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The increased amount of exits for fund were in 2018.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Allogene Therapeutics, BridgeBio, Alector. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Genetics, Biopharma.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Perceptive Advisors, startups are often financed by Third Rock Ventures, F-Prime Capital, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are ArrowMark Partners, RTW Investments LLC, Viking Global Investors. In the next rounds fund is usually obtained by OrbiMed, Pontifax, Warburg Pincus.

Related Funds

Funds investing in previous rounds

These funds often invest in the rounds preceeding the rounds of Perceptive Advisors:

1 OrbiMed

2 Biotechnology Value Fund

3 RA Capital Management

Typical Co-investors

Perceptive Advisors is more likely to invest in rounds together with the following funds:

1 Advanced Info Service

2 Cardinal Capital Partners

3 ComVentures

Funds investing in following rounds

These funds have a tendency to invest in the following rounds after Perceptive Advisors:

1 Paladin

2 Nielsen

3 Sunstone Partners

Funds with similar focus

Funds from United States, New York

Funds with similar focus located in United States, New York:

1 New Enterprise Associates

2 Norwest Venture Partners

3 Venrock

4 Lightspeed Venture Partners

5 GV

Funds with the same geo focus

Funds with similar geography of portfolio companies:

1 U.S. Venture Partners

2 Menlo Ventures

3 Trinity Ventures

4 Canaan Partners

5 Benchmark

Funds doing lead investments

Funds with similar focus acting as lead investors:

1 Plains Venture Partners

2 Crystal Amber

3 Tasly Great Health Industry Fund

4 Aspen MedTech

5 Ares Life Sciences

Notable deals

Company	Industry	Round	Round Size	Date	Investors	Location
Emulate	Biotechnology Commercial Health Care Life Science Medical	1	$82M	07 Sep 2021	Perceptive Advisors Northpond Ventures	United States, Boston
Genome Medical	Genetics Health Care Life Science Medical	1	$60M	30 Aug 2021	Kaiser Permanente Ventures Perceptive Advisors Amgen Ventures Avestria Ventures Dreamers VC Echo Health Ventures Canaan Partners Blue Ivy Ventures GV Casdin Capital Illumina Ventures LRVHealth Revelation Partners HealthInvest Equity Partners Flywheel Ventures	United States, South San Francisco
Bridge to Life Ltd.	Biotechnology	n/a	$56M	19 Aug 2021	Perceptive Advisors	United States, Northbrook
Zentera Therapeutics	Biotechnology Pharmaceutical	1	$75M	04 Aug 2021	Perceptive Advisors OrbiMed Redmile Group Logos Capital Surveyor Capital Lilly Asia Ventures Viking Global Investors Farallon Capital Management Casdin Capital Avidity Partners Tybourne Capital Management	China, Shanghai
Sema4	Artificial Intelligence Health Care Health Diagnostics Machine Learning Medical Predictive Analytics	n/a	$350M	23 Jul 2021	Perceptive Advisors T. Rowe Price Viking Global Investors Fidelity Management and Research Company Deerfield Management Counterpoint Global BlackRock SoftBank Capital Casdin Capital	United States, Stamford
Point Biopharma	Biopharma Biotechnology Therapeutics	n/a	$165M	01 Jul 2021	Perceptive Advisors Johnson & Johnson Innovation – JJDC Suvretta Capital Management Surveyor Capital BVF Partners Boxer Capital Sphera Global Healthcare Fund Farallon Capital Management RA Capital Management Woodline Partners Fairmount Funds Management	United States, Indianapolis
PROCEPT BioRobotics	Biotechnology Health Care Medical Device Robotics	1	$85M	30 Jun 2021	Perceptive Advisors Duquesne Family Office Fidelity Management and Research Company Viking Global Investors T. Rowe Price CPMG	United States, Redwood City
Nautilus Biotechnology	Biotechnology Life Science Pharmaceutical	n/a	$200M	10 Jun 2021	Perceptive Advisors OrbiMed Alyeska Investment Group Andreessen Horowitz Vulcan Capital Madrona Venture Group Bain Capital Life Sciences Ally Bridge Group RA Capital Management Casdin Capital Franklin Templeton Investments	United States, " United States"}
NiKang Therapeutics	Biotechnology Health Care Medical	1	$200M	26 May 2021	Perceptive Advisors Wellington Management Surveyor Capital Samsara BioCapital RTW Investments LLC RA Capital Management PFM Health Sciences Pavilion Capital Octagon Capital Advisors Matrix Partners China Logos Capital Lilly Asia Ventures Janus Henderson Investors Invus HBM Healthcare Investments AG EcoR1 Capital Cormorant Asset Management Casdin Capital BlackRock Ally Bridge Group C-Bridge Capital	United States, Wilmington

News

HilleVax Closes $135 Million Crossover Financing to Advance Clinical Stage Norovirus Vaccine Candidate
– HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates, announced the close of a $135 million crossover financing led by Frazier Healthcare Partners and joined by RA Capital Management, Deerfield Management Company, Abingworth, Lightspeed Venture Partners, Perceptive Advisors, Catalys Pacific, Samsara BioCapital, BVF Partners, Qiming Venture Partners USA, Greenspring Associates, Richard King Mellon Foundation, and Sahsen Ventures. – The pro... Read more

Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market
– Emulate, Inc. announced the close of an $82m Series E financing round. – The round was led by Northpond Ventures with additional participation from Perceptive Advisors. – With this investment, Emulate has raised nearly $225m to date. – Emulate develops and manufactures next-generation in vitro models that enable researchers to replicate and study human biology and disease, helping them understand and predict drug response with greater precision and detail than possible with conventional cell culture or a... Read more

Read All News